Consent Matters
Marketing consent challenges for European-based pharmaceutical companies
With the explosion of customer data it might seem as if customer communications should grow in scope
With the explosion of customer data it might seem as if customer communications should grow in scope, reacting to address needs and interests, correspondingly increasing customer interactions and interruption. But does personalisation have to mean more communication and intrusion?
the pursuit of providing more relevant interactions but interrupting the customer less
In our work over the last 3.5 years we are finding a naturally occurring bell curve as organisations amass vast data assets and seek to maximise customer intelligence & targeting. This is all in the cause of creating a more controlled and customer centric approach to marketing, in the pursuit of providing more relevant interactions but interrupting the customer less. With this transition comes the double benefit of more effective customer communications; driving commercial outcomes and improved customer experience which in turn drives satisfaction & loyalty.
Increasingly our client's ambitions are evolving from 'data-driven' to 'customer-centric and relevant'. This is a step-change in thinking for two reasons:
focussed attention on realising actual customer value from data and a need to apply controls to profiling & targeting
This change appears to be explicitly driven from a combination of commercial and regulatory dynamics which have focussed attention on realising actual customer value from data and a need to apply controls to profiling & targeting. These dynamics are perhaps the catalysts for affecting genuine change.
As we so often observe in our own consumer relationships, there is in fact very little evidence of real data-driven experience in our everyday lives and their remains significant opportunities to increase relevance in both what is said and how it is delivered.
Marketing consent challenges for European-based pharmaceutical companies
She brings a wealth of extremely valuable client-side and vendor experience that will be very beneficial
Can pharmaceutical companies embrace great UX design in their modern commercial digital and marketing operations...